Who is sponsoring NCT04796792?

NCT04796792 is sponsored by University of Washington.

What drugs are being tested in NCT04796792?

Interventions in NCT04796792: Burst Wave Lithotripsy (BWL) and Ultrasonic Propulsion (UP).

What condition does NCT04796792 study?

NCT04796792 studies Urinary Stone, Urinary Calculi.

Is NCT04796792 still recruiting?

NCT04796792 is currently recruiting now. Last updated 9 December 2025.

Last reviewed 2025-12-09 · How we verify

NCT04796792

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ultrasound to Facilitate Stone Passage

Recruiting now NA Last updated 9 December 2025

What this trial tests

NA trial testing Burst Wave Lithotripsy (BWL) and Ultrasonic Propulsion (UP) in Urinary Stone in 140 participants. Currently enrolling.

Timeline

1 April 2023

Primary endpoint
31 May 2028

31 October 2028

Quick facts

Lead sponsor	University of Washington
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	140
Start date	1 April 2023
Primary completion	31 May 2028
Estimated completion	31 October 2028
Sites	3 locations across United States

Drugs / interventions tested

Burst Wave Lithotripsy (BWL) and Ultrasonic Propulsion (UP)

Conditions studied

Urinary Stone — all drugs for Urinary Stone →
Urinary Calculi — all drugs for Urinary Calculi →

Sponsor

University of Washington

Who can join

18 and older, any sex, with Urinary Stone or Urinary Calculi. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, open-label, multi-center study to test the clinical feasibility of facilitating stone passage by the combination of breaking and repositioning stones with ultrasound, without the need for anesthesia.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Improving Burst Wave Lithotripsy Effectiveness for Small Stones and Fragments by Increasing Frequency: Theoretical Modeling and <i>Ex Vivo</i> Study.
Bailey MR, Maxwell AD, Cao S, Ramesh S, et al · · 2022 · cited 5× · PMID 35229652 · DOI 10.1089/end.2021.0714
Burst wave lithotripsy - a paradigm shift: inferences from a scoping review.
Yuen SKK, Gauhar V, Chai CA, Forbes CM, et al · · 2025 · PMID 40278907 · DOI 10.1007/s00345-025-05645-x
Re: First Series Using Ultrasonic Propulsion and Burst Wave Lithotripsy to Treat Ureteral Stones. Reply.
Kennedy Hall M, Sorensen MD, Bailey MR. · · 2023 · PMID 36383752 · DOI 10.1097/ju.0000000000003061
Removal of Small, Asymptomatic Kidney Stones and Relapse. Reply.
Sorensen MD, Bailey MR, Lingeman JE. · · 2022 · PMID 36351279 · DOI 10.1056/nejmc2212541

Verify or expand the search:

Other recruiting trials for Urinary Stone

Currently open trials in the same condition.

NCT06628765 — Two Types of Single-use Flexible Ureteroscopies for the Treatment of Upper Urinary Tract Stones in Children · NA · recruiting
NCT06412900 — Radiomics and Image Segmentation of Urinary Stones by Artificial Intelligence · active not recruiting

Other University of Washington trials

Trials by the same sponsor.

NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04796792 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Washington
Last refreshed: 9 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04796792.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing